Mirum Pharmaceuticals Inc (MIRM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.14B
Last updated: Nov 17, 2026 at 11:05 AM ET
Mirum Pharmaceuticals Inc (MIRM) Competitors
The companies most similar to Mirum Pharmaceuticals are Madrigal Pharmaceuticals (MDGL), Disc Medicine (IRON) and Travere Therapeutics (TVTX). By market cap, Mirum Pharmaceuticals ranks 8th of the 13 companies on this page; Summit Therapeutics (SMMT) is the largest at $11.32B.
Peer Comparison
MIRM's ROIC of -133.6% is below the peer median of -23.1%, and its revenue growth of 39.6% is below the median of 43.2%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals (MIRM) | $6.14B | N/A | 8.9x | -134.7% | -133.6% | 39.6% | 0.00% |
| Madrigal Pharmaceuticals Inc (MDGL) | $9.93B | N/A | 8.7x | -10.9% | -12.7% | 50.1% | 0.00% |
| Disc Medicine Inc. (IRON) | $3.64B | N/A | N/A | 0.0% | -40.0% | 0.0% | 0.00% |
| Travere Therapeutics Inc (TVTX) | $4.86B | N/A | 7.2x | -18.7% | -23.1% | 36.2% | 0.00% |
| Rhythm Pharmaceuticals Inc (RYTM) | $7.97B | N/A | 26.4x | -69.0% | -98.6% | 79.6% | 0.00% |
| Ligand Pharmaceuticals Incorporated (LGND) | $6.18B | 66.5x | 23.7x | 20.3% | 0.1% | -31.8% | 0.00% |
| PTC Therapeutics Inc (PTCT) | $5.30B | N/A | 5.2x | -9.2% | 18.1% | 69.6% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| Praxis Precision Medicines Inc (PRAX) | $9.17B | N/A | N/A | 0.0% | N/A | 1349.0% | 0.00% |
| Scholar Rock Holding Corp (SRRK) | $5.27B | N/A | N/A | 0.0% | -89.0% | -100.0% | 0.00% |
| Immunovant Inc (IMVT) | $7.07B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Dianthus Therapeutics Inc. (DNTH) | $5.17B | N/A | N/A | 0.0% | N/A | 205.6% | 0.00% |
| Summit Therapeutics PLC (SMMT) | $11.32B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Peer median | $6.63B | 47.1x | 12.2x | 0.0% | -23.1% | 43.2% | 0.00% |
Similar Companies
These are the 12 companies most similar to Mirum Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Madrigal Pharmaceuticals Inc (MDGL) | Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates... | MDGL competitors |
| Disc Medicine Inc. (IRON) | Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development... | IRON competitors |
| Travere Therapeutics Inc (TVTX) | Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification... | TVTX competitors |
| Rhythm Pharmaceuticals Inc (RYTM) | Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment... | RYTM competitors |
| Ligand Pharmaceuticals Incorporated (LGND) | Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover... | LGND competitors |
| PTC Therapeutics Inc (PTCT) | PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. | PTCT competitors |
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| Praxis Precision Medicines Inc (PRAX) | Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal... | PRAX competitors |
| Scholar Rock Holding Corp (SRRK) | Scholar Rock Holding Corporation, a clinical-phase biopharmaceutical company, is focused on the discovery and development of drugs for the treatment of serious... | SRRK competitors |
| Immunovant Inc (IMVT) | Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. | IMVT competitors |
| Dianthus Therapeutics Inc. (DNTH) | Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops... | DNTH competitors |
| Summit Therapeutics PLC (SMMT) | Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America... | SMMT competitors |
Frequently Asked Questions About MIRM
Who are Mirum Pharmaceuticals' main competitors?
The companies most similar to Mirum Pharmaceuticals include Madrigal Pharmaceuticals (MDGL), Disc Medicine (IRON), Travere Therapeutics (TVTX), Rhythm Pharmaceuticals (RYTM) and Ligand Pharmaceuticals (LGND), listed from the closest match.
Who is Mirum Pharmaceuticals' biggest competitor?
Summit Therapeutics (SMMT) is the largest of the similar companies at $11.32B; Madrigal Pharmaceuticals (MDGL) is the closest match by business profile, size, sector and industry.
How does MIRM stock compare with its competitors?
MIRM's P/S is 8.9x against a peer median of 12.2x; its net margin is -134.7% against a peer median of 0.0%.
Which of Mirum Pharmaceuticals' competitors pays a higher dividend?
Mirum Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Mirum Pharmaceuticals bigger than its competitors?
No. Mirum Pharmaceuticals is 8th by market cap among the 13 companies on this page; the largest is Summit Therapeutics (SMMT) at $11.32B.
MIRM pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts